17-(3-pyridyl)-5,16-androstadien-3beta-acetate 154229-18-2

17-(3-pyridyl)-5,16-androstadien-3beta-acetate 154229-18-2
Send Inquiry
Product Code : 154229-18-2
Brand Name : DM
Price And Quantity
  • Minimum Order Quantity
  • 1g Gram
  • Price Range
  • 10.00 - 50.00 USD ($)
Product Specifications
  • Melting Point
  • 260.2ºC
  • Boiling point
  • 506.7ºC at 760mmHg
  • Taste
  • Odorless
  • Molecular Formula
  • C26H33NO2
  • Shelf Life
  • 2 Years
  • Molecular Weight
  • 391.55 Kilograms (kg)
  • Storage
  • Freezer
  • HS Code
  • 2937290000
  • Smell
  • No Smell
  • Structural Formula
  • C26H33NO2
  • 620-314-7
  • Medicine Name
  • 17-(3-pyridyl)-5,16-androstadien-3beta-acetate
  • Chemical Name
  • (3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate
  • CAS No
  • 154229-18-2
  • Type
  • Pharmaceutical Intermediates
  • Grade
  • Medicine Grade
  • Usage
  • The Abiraterone acetate, with the cas registry number 154229-18-2, has the systematic name of (3β)-17-(pyridin-3-yl)androsta-5,16-dien-3-yl acetate. It belongs to the following product categories: Intermediates & Fine Chemicals; Pharmaceuticals; Steroids. And the molecular formula of the chemical is C26H33NO2. Abiraterone acetate is a drug used in castration-resistant prostate cancer (formerly hormone-resistant or hormone-refractory prostate cancer) Abiraterone acetate is indicated for use in combination with prednisone, a corticosteroid, as a treatment for mCRPC (previously called hormone-resistant or hormone-refractory prostate cancer). This is a form of prostate cancer that is not responding to first-line androgen deprivation therapy or treatment with androgen receptor antagonists. Abiraterone acetate has received FDA (28 April 2011), EMA (23 September 2011), MHRA (5 September 2011) and TGA (1 March 2012) approval for this indication. In Australia it is covered by the Pharmaceutical Benefits Scheme when being used to treat castration-resistant prostate cancer and given in combination with prednisone/prednisolone (subject to the conditions that the patient is not currently receiving chemotherapy, is either resistant or intolerant of docetaxel, has a WHO performance status of <2, and his disease has not since become progressive since treatment with PBS-subsidised abiraterone acetate has commenced). Abiraterone may be useful for prevention of the testosterone flare at the initiation of GnRH agonist therapy in men with prostate cancer.
  • Purity(%)
  • 99
  • Appearance
  • white powder
  • Physical Form
  • Powder
Product Description

Product Name



White Powder



Molecular Formula


Molecular Weight




Boiling Point

506.7oC at 760mmHg

Flash Point



99% min

Trade Information
  • FOB Port
  • any port in China
  • Payment Terms
  • Cash Against Delivery (CAD), Cash in Advance (CID), Days after Acceptance (DA), Letter of Credit at Sight (Sight L/C), Paypal
  • Supply Ability
  • 100kgs Per Month
  • Delivery Time
  • 1 Week
  • Sample Policy
  • Within a certain price range free samples are available
  • Packaging Details
  • as per request
  • Main Domestic Market
  • All India
  • Certifications
  • ISO9001

Get in touch with us
RFQ Request For Quotation
Get Quotes For Your Buying Requirement. Tell Suppliers What You Need.
I agree to abide by all the Terms and Conditions of tradeindia.com